Drug Pipeline

Vosoritide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06455059 Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia Hypochondroplasia Active, Not Recruiting
NCT03424018 An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With… Achondroplasia Active, Not Recruiting
Phase 2
NCT07126262 A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36… Hypochondroplasia Recruiting
NCT02724228 A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children… Achondroplasia Active, Not Recruiting
NCT04554940 A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia Achondroplasia Active, Not Recruiting
NCT04219007 Vosoritide for Selected Genetic Causes of Short Stature Short Stature Active, Not Recruiting
Sponsors Running Vosoritide Trials
BioMarin Pharmaceutical (5) Andrew Dauber (1)
Get alerts when Vosoritide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free